BCOR-CCNB3 fusion-positive soft tissue sarcoma: A case report and literature review

Authors

  • Siripuk Sawetchaikul Department of Surgery, Nopparat Rajathanee Hospital Bangkok, Thailand
  • Tasama Pusongchai Department of Pediatrics, Thammasat University Hospital, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand
  • Utairat Chaumrattanakul Department of Radiology, Thammasat University Hospital, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand
  • Jutatip Kintarak Department of Pathology and Forensic Medicine, Thammasat University Hospital, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand
  • Artit Jinawath Department of Pathology, Ramathibodi Hospital, Mahidol University Bangkok, Thailand
  • Pacharapan Surapolchai Department of Pediatrics, Thammasat University Hospital, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand
  • Pakatip Sinlapamongkolkul Department of Pediatrics, Thammasat University Hospital, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand

Keywords:

BCOR-CCNB3 sarcoma, undifferentiated sarcoma, acute myeloblastic leukemia

Abstract

BCOR-CCNB3 sarcoma is one of a group of undifferentiated sarcomas. The objective of this case report was to describe the clinical and pathological data of a patient with this tumor. Our patient was a 14-year-old male adolescent with right flank pain. Imaging revealed a psoas muscle mass lesion. Histology and gene expression were suggestive of BCOR-CCNB3 sarcoma. Chemotherapy, surgery, and radiotherapy were used according to the Ewing sarcoma protocol in Thailand. Unfortunately, our patient died from acute myeloblastic leukemia (M5) without remission despite chemotherapy.

References

Pierron G, Tirode F, Lucchesi C, et al. A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. Nat Genet. 2012;44(4):461-466. https://doi.org/10.1038/ng.1107

Cohen-Gogo S, Cellier C, Coindre JM, et al. Ewing-like sarcomas with BCOR-CCNB3 fusion transcript: a clinical, radiological and pathological retrospective study from the Société Française des Cancers de L'Enfant. Pediatr Blood Cancer. 2014;61(12):2191-2198. https://doi.org/10.1002/pbc. 25210

Puls F, Niblett A, Marland G, et al. BCOR-CCNB3 (Ewing-like) sarcoma: a clinicopathologic analysis of 10 cases, in comparison with conventional Ewing sarcoma. Am J Surg Pathol. 2014;38(10):1307-1318. https://doi.org /10.1097/PAS. 0000000000000223

Peters TL, Kumar V, Polikepahad S, et al. BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children. Mod Pathol. 2015;28(4):575-586. https://doi.org/10.1038/modpathol.2014.139

Shibayama T, Okamoto T, Nakashima Y, et al. Screening of BCOR-CCNB3 sarcoma using immunohistochemistry for CCNB3: A clinicopathological report of three pediatric cases. Pathol Int. 2015;65(8):410-414. https://doi.org /10.1111/ pin.12319

Li WS, Liao IC, Wen MC, Lan HH, Yu SC, Huang HY. BCOR-CCNB3-positive soft tissue sarcoma with round-cell and spindle-cell histology: a series of four cases highlighting the pitfall of mimicking poorly differentiated synovial sarcoma. Histopathology. 2016;69(5):792-801. https://doi.org/10.1111/his.13001

Ludwig K, Alaggio R, Zin A, et al. BCOR-CCNB3 undifferentiated sarcoma-does immunohistochemistry help in the identification? Pediatr Dev Pathol. 2017;20(4):321-329. https://doi.org/10.1177/1093526617698263

Matsuyama A, Shiba E, Umekita Y, et al. Clinicopathologic diversity of undifferentiated sarcoma with BCOR-CCNB3 fusion: analysis of 11 cases with a reappraisal of the utility of immunohistochemistry for BCOR and CCNB3. Am J Surg Pathol. 2017;41(12):1713-1721. https://doi: 10.1097/PAS.0000 000000000934

Kao YC, Owosho AA, Sung YS, et al. BCOR-CCNB3 fusion positive sarcomas: a clinicopathologic and molecular analysis of 36 cases with comparison to morphologic spectrum and clinical behavior of other round cell sarcomas. Am J Surg Pathol. 2018;42(5):604-615. https://doi.org/10.1097/PAS.00000000 00000965

The Thai Society of Hematology. National protocol for the treatment of childhood cancers 2016. Bangkok: Sahamitr Printing and Publishing; 2016.

Alfaro-Cervello C, Andrade-Gamarra V, Nieto G, et al. Congenital undifferentiated sarcoma associated to BCOR-CCNB3 gene fusion. Pathol Res Pract. 2017;213(11):1435-1439. https://doi.org/10.1016/j.prp.2017.07.012

Argani P, Kao YC, Zhang L, et al. Primary renal sarcomas with BCOR-CCNB3 gene fusion: a report of 2 cases showing histologic overlap with clear cell sarcoma of kidney, suggesting further link between BCOR-related sarcomas of the kidney and soft tissues. Am J Surg Pathol. 2017;41(12):1702-1712. https://doi.org/10.1097/PAS.0000000000000926

Wong MK, Ng CCY, Kuick CH, et al. Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR-CCNB3 gene fusion. Histopathology. 2018;72(2):320-329. https://doi.org/10.1111/his.13366

Felix CA. Leukemias related to treatment with DNA topoisomerase II inhibitors. Med Pediatr Oncol. 2001;36(5):525-535. https://doi.org/10.1002 /mpo.1125

Davies SM. Therapy-related leukemia associated with alkylating agents. Med Pediatr Oncol. 2001;36(5):536-540. https://doi.org/10.1002/mpo.1126

Hijiya N, Ness KK, Ribeiro RC, Hudson MM. Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues. Cancer. 2009;115(1):23-35. https://doi.org/10.1002/cncr.23988

Hijiya N, Hudson MM, Lensing S, et al. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA. 2007;297(11):1207-1215. https://doi.org/10.1001/jama.297.11.1207

Pui CH, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med. 1991;325(24):1682-1687. https://doi.org/10.1056/NEJM19911212325240 2

Hijiya N, Gajjar A, Zhang Z, et al. Low-dose oral etoposide-based induction regimen for children with acute lymphoblastic leukemia in first bone marrow relapse. Leukemia. 2004;18(10):1581-1586. https://doi.org/10.1038/sj. leu.2403 467

Sandoval C, Pui CH, Bowman LC, et al. Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation. J Clin Oncol. 1993;11(6):1039-1045. https://doi.org/10.1200/JCO.1993.11.6.1039

Pedersen-Bjergaard J, Philip P, Larsen SO, et al. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia. 1993;7(12):1975-1986.

Kushner BH, Cheung NK, Kramer K, Heller G, Jhanwar SC. Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review. J Clin Oncol. 1998;16(12):3880-3889. https://doi.org/10.1200/JCO.1998.16.12.3880

Bhatia S, Krailo MD, Chen Z, et al. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. Blood. 2007;109(1):46-51. https://doi.org/10.1182/blood-2006-01-023101

Smith MA, Rubinstein L, Anderson JR, et al. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol. 1999;17(2):569-577. https://doi.org/10.1200/JCO.1999.17.2.569

Kyriazoglou A, Bagos P. Meta-analysis of BCOR rearranged sarcomas: challenging the therapeutic approach. Acta Oncol. 2021;60(6):721-726. https://doi.org/10.1080/0284186X.2021.1890818

Grossmann V, Tiacci E, Holmes AB, et al. Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype. Blood. 2011;118(23):6153-63. https://doi: 10.1182/blood-2011-07-365320

Yamato A, Soda M, Ueno T, et al. Oncogenic activity of BIRC2 and BIRC3 mutants independent of nuclear factor-κB-activating potential. Cancer Sci. 2015;106(9):1137-1142. https://doi.org/10.1111/cas.12726

Hijiya N, Ness KK, Ribeiro RC, et al. Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues. Cancer. 2009;115(1):23–35. https://doi:10.1002/cncr.23988

Downloads

Published

2023-10-01

How to Cite

1.
Sawetchaikul S, Pusongchai T, Chaumrattanakul U, Kintarak J, Jinawath A, Surapolchai P, Sinlapamongkolkul P. BCOR-CCNB3 fusion-positive soft tissue sarcoma: A case report and literature review. J Chulabhorn Royal Acad [Internet]. 2023 Oct. 1 [cited 2024 Jul. 1];5(4):243-52. Available from: https://he02.tci-thaijo.org/index.php/jcra/article/view/258530

Issue

Vol. 5 No. 4 (2023): October - December

Section

Academic Articles

License

Copyright (c) 2023 Chulabhorn Royal Academy

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของราชวิทยาลัยจุฬาภรณ์

ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับราชวิทยาลัยจุฬาภรณ์ และคณาจารย์ท่านอื่น ในราชวิทยาลัยฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใด ๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว